{
    "Trade/Device Name(s)": [
        "Jaundice Meter JM-105"
    ],
    "Submitter Information": "Draeger Medical Systems, Inc.",
    "510(k) Number": "K133175",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042522"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "MQM"
    ],
    "Summary Letter Date": "September 26, 2014",
    "Summary Letter Received Date": "September 26, 2014",
    "Submission Date": "November 6, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1113"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total and unbound) in the neonate test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Bilirubin"
    ],
    "Specimen Type(s)": [
        "Subcutaneous tissue (newborn infant skin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Jaundice Meter JM-105"
    ],
    "Method(s)/Technology(ies)": [
        "Transcutaneous optical measurement",
        "Non-invasive spectrophotometry"
    ],
    "Methodologies": [
        "Optical density difference at two wavelengths"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Draeger Jaundice Meter JM-105, a non-invasive transcutaneous bilirubinometer for newborn infants",
    "Indications for Use Summary": "Intended to assist clinicians in monitoring newborn infants for hyperbilirubinemia via non-invasive measurement of yellowness of subcutaneous tissue, used in hospitals, clinics, or physician offices under supervision and in conjunction with other clinical signs and laboratory measurements",
    "fda_folder": "Clinical Chemistry"
}